Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Long-Term Follow-Up of Renal Transplant Recipients (RTR) Treated with IVIG for De Novo Donor Specific Antibodies (DSA).
R. Knight,¹ S. Patel,¹ J. Loucks-DeVos,² S. Kuten,¹ A. Gaber.¹
¹Houston Methodist Hospital, Houston, TX; ²Kansas University Medical Center, Kansas City, KS.
Intravenous immune globulin (IVIG) may be beneﬁcial for pre-emptive treatment of de novo DSA in RTR without biopsy-proven acute rejection (AR). Herein, we present long-term…
2016 American Transplant Congress
Outcomes of Kidney Transplantation in Obese Recipients – Single Center Experience.
A. El-Hinnawi, A. Rajab, G. Bumgardner, L. Haj Naser, R. Plews, I. James, M. Henry, R. Pelletier.
Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
Background: With the obesity epidemic, there is an increased prevalence of obesity amongst patients with ESRD. Controversy exists regarding post-transplant outcomes in obese kidney transplant…
2016 American Transplant Congress
Correlation of the Shear Wave Elastography with Renal Function in Kidney Transplant Recipients: A Proof of Concept Study.
J. Dosal-Bañuelos, A. Flores-Mendoza, L. Morales-Buenrostro, M. Díaz-Zamudio.
Radiology and Nephrology, National Institute of Medical Sciences and Nutrition SZ, México, Distrito Federal, Mexico.
Background: Non-invasive biomarker for kidney allograft fibrosis is needed. Shear wave elastography is a relatively new technique to assess tissue stiffness. Graft rejection and chronic…
2016 American Transplant Congress
Non-adherence to Appointments Is a Strong Predictor of Medication Non-Adherence and Outcomes in Kidney Transplant Recipients.
M. Posadas Salas, R. Pullalarevu, M. Kamel, A. Chokkalingam, R. Browning, B. Kadri, M. Salazar, T. Srinivas, D. Taber.
Medical University of South Carolina, Charleston, SC.
Disparities in healthcare access and non-adherence are important aspects of transplantation that affect outcomes. This study aims to investigate the impact of non-adherence to laboratory…
2016 American Transplant Congress
Comparison of Low Dose and Very Low Dose Extended-Release Tacrolimus / MMF in De Novo Kidney Transplant Recipients.
Y. Watarai,¹ M. Okada,¹ K. Futamura,¹ T. Nagai,¹ T. Yamamoto,¹ M. Tsujita,¹ T. Hiramitsu,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²
¹Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; ²Kidney Transplantation, Aichi Medical University, Nagoya, Aichi, Japan.
Recently, once-daily tacrolimus extended-release formulation (TACER) has been accepted in kidney transplantation, however its optimal dosing are not well evaluated. We have validated low dose…
2016 American Transplant Congress
Elderly Kidney Transplant Recipients Need Optimized Immunosuppression According to Comorbidity and Infection.
E. Kang,¹ S. Park,¹ S. Park,¹ S. Yang,² I. Jung,³ S.-K. Park,⁴ Y. Kim,⁵ D.-J. Han,¹ Y. Kim,¹ J. Lee.⁶
¹Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; ²Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea; ³Department of Surgery, Seoul National University Boramae Medical Center, Seoul, Korea; ⁴Department of Internal Medicine, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; ⁵Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; ⁶Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
Backgrounds: The numbers of elderly kidney transplantation is increasing, but there are limited studies about the use of immunosuppressant in this group. We investigated the…
2016 American Transplant Congress
Clinical Correlation Between Pairs of Kidneys Transplanted from the Same Donor.
A. Baheerathan, H. Beckwith, A. McLean, D. Taube, M. Willicombe.
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
Introduction: Concordance of allograft outcomes between kidneys transplanted from the same donor has previously been reported. However recipient characteristics become increasingly important after the immediate…
2016 American Transplant Congress
Circulating Soluble-Klotho Levels Modestly Increase After Renal Transplantation.
S.-J. Tan,¹ A. Crosthwaite,² D. Langsford,³ V. Obeysekere,⁴ F. Ierino,^2,5 M. Roberts,^5,6 S. Holt,¹ T. Hewitson,¹ K. Dwyer,^3,5,7 N. Toussaint.¹
¹Dept of Nephrology, The Royal Melbourne Hospital, Melbourne, Australia; ²Dept of Nephrology, Austin Hospital, Heidelberg, Victoria, Australia; ³Dept of Nephrology, St Vincent's Hospital, Melbourne, Australia; ⁴Dept of Endocrinology, St Vincent's Hospital, Melbourne, Australia; ⁵Victorian Kidney Transplantation Collaborative, Melbourne, Australia; ⁶Dept of Renal Medicine, Eastern Health, Box Hill, Australia; ⁷School of Medicine, Deakin University, Geelong, Australia.
Background: Klotho, a co-receptor for FGF23, is predominantly expressed in kidney and reported to have anti-oxidant and anti-fibrotic properties. Soluble-Klotho (sKl), the cleaved circulating protein,…
2016 American Transplant Congress
Antibody-Mediated Rejection Can Be Assessed by Histology When DSA Is Unknown or Negative.
J. Reeve,¹ P. Halloran.²
¹Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada; ²Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Diagnosis of antibody-mediated rejection (ABMR) in kidney transplants currently requires the presence of donor-specific antibody (DSA) and histologic lesions above somewhat arbitrary cutoffs. DSA is…
2016 American Transplant Congress
Induction Agent Use and Outcomes in Older KT Recipients: Patient and Center Level Associations.
M. McAdams-DeMarco, Q. Huang, X. Luo, B. Orandi, S. Dorry.
Johns Hopkins, Baltimore.
Background: Clinical trials of induction agents typically exclude older recipients, so our practice in older recipients is extrapolated from this. Older adults are different, so…